Search Results

There are 41262 results for: content related to: The impact of interacting drugs on dispensed doses of warfarin in the Swedish population: A novel use of population based drug registers

  1. You have free access to this content
    The Pharmacology and Therapeutic Use of Dabigatran Etexilate

    The Journal of Clinical Pharmacology

    Volume 53, Issue 1, January 2013, Pages: 1–13, Spinler Sarah

    Version of Record online : 24 JAN 2013, DOI: 10.1177/0091270011432169

  2. Warfarin-drug interactions: An emphasis on influence of polypharmacy and high doses of amoxicillin/clavulanate

    The Journal of Clinical Pharmacology

    Volume 56, Issue 1, January 2016, Pages: 39–46, Mahmoud I. Abdel-Aziz, Mostafa A. Sayed Ali, Ayman K. M. Hassan and Tahani H. Elfaham

    Version of Record online : 29 SEP 2015, DOI: 10.1002/jcph.583

  3. Potential Underprediction of Warfarin Drug Interaction From Conventional Interaction Studies and Risk Mitigation: A Case Study With Epacadostat, an IDO1 Inhibitor

    The Journal of Clinical Pharmacology

    Volume 56, Issue 11, November 2016, Pages: 1344–1354, Jack G. Shi, Xuejun Chen, Naresh G. Punwani, William V. Williams and Swamy Yeleswaram

    Version of Record online : 29 APR 2016, DOI: 10.1002/jcph.737

  4. You have full text access to this OnlineOpen article
    Lack of effect of multiple doses of vortioxetine on the pharmacokinetics and pharmacodynamics of aspirin and warfarin

    The Journal of Clinical Pharmacology

    Volume 55, Issue 6, June 2015, Pages: 671–679, Grace Chen, Wencan Zhang and Michael Serenko

    Version of Record online : 4 FEB 2015, DOI: 10.1002/jcph.456

  5. Effect of CYP2C9–VKORC1 interaction on warfarin stable dosage and its predictive algorithm

    The Journal of Clinical Pharmacology

    Volume 55, Issue 3, March 2015, Pages: 251–257, Xi Li, Rong Liu, Han Yan, Jie Tang, Ji-Ye Yin, Xiao-Yuan Mao, Fang Yang, Zhi-Yin Luo, Sheng-Lan Tan, Hui He, Xiao-Ping Chen, Zhao-Qian Liu, Zhi Li, Hong-Hao Zhou and Wei Zhang

    Version of Record online : 16 SEP 2014, DOI: 10.1002/jcph.392

  6. Genes affecting warfarin response—interactive or additive?

    The Journal of Clinical Pharmacology

    Volume 55, Issue 3, March 2015, Pages: 258–260, Larisa H. Cavallari and Julio D. Duarte

    Version of Record online : 30 DEC 2014, DOI: 10.1002/jcph.425

  7. CYP2C9 Genotype-Dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites

    The Journal of Clinical Pharmacology

    Volume 57, Issue 3, March 2017, Pages: 382–393, Darcy R. Flora, Allan E. Rettie, Richard C. Brundage and Timothy S. Tracy

    Version of Record online : 22 SEP 2016, DOI: 10.1002/jcph.813

  8. A systematic review on comparing 2 common models for management of warfarin therapy; pharmacist-led service versus usual medical care

    The Journal of Clinical Pharmacology

    Volume 56, Issue 1, January 2016, Pages: 24–38, Taher Entezari-Maleki, Samaneh Dousti, Hadi Hamishehkar and Kheirollah Gholami

    Version of Record online : 21 SEP 2015, DOI: 10.1002/jcph.576

  9. Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib

    The Journal of Clinical Pharmacology

    Volume 55, Issue 4, April 2015, Pages: 392–400, A. Benjamin Suttle, Kenneth F. Grossmann, Daniele Ouellet, Lauren E. Richards-Peterson, Gursel Aktan, Michael S. Gordon, Patricia M. LoRusso, Jeffrey R. Infante, Sunil Sharma, Kari Kendra, Manish Patel, Shubham Pant, Hendrik-Tobias Arkenau, Mark R. Middleton, Samuel C. Blackman, Jeff Botbyl and Stanley W. Carson

    Version of Record online : 30 DEC 2014, DOI: 10.1002/jcph.437

  10. Meta-analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling

    The Journal of Clinical Pharmacology

    Volume 56, Issue 3, March 2016, Pages: 266–283, Vijay V. Upreti and Jan L. Wahlstrom

    Version of Record online : 9 OCT 2015, DOI: 10.1002/jcph.585

  11. Warfarin usage among elderly atrial fibrillation patients with traumatic injury, an analysis of United States Medicare fee-for-service enrollees

    The Journal of Clinical Pharmacology

    Volume 55, Issue 1, January 2015, Pages: 25–32, Xinggang Liu, Mona Baumgarten, Gordon Smith, Steven Gambert, Stephen Gottlieb, Gail Rattinger, Jennifer Albrecht, Patricia Langenberg and Ilene Zuckerman

    Version of Record online : 11 AUG 2014, DOI: 10.1002/jcph.375

  12. The effect of single- and multiple-dose etravirine on a drug cocktail of representative cytochrome P450 probes and digoxin in healthy subjects

    The Journal of Clinical Pharmacology

    Volume 54, Issue 4, April 2014, Pages: 422–431, Thomas N. Kakuda, Rodica M. Van Solingen-Ristea, Joelle Onkelinx, Tanja Stevens, Fatima Aharchi, Goedele De Smedt, Monika Peeters, Lorant Leopold and Richard M.W. Hoetelmans

    Version of Record online : 19 NOV 2013, DOI: 10.1002/jcph.214

  13. Small-Molecule Compounds Exhibiting Target-Mediated Drug Disposition (TMDD): A Minireview

    The Journal of Clinical Pharmacology

    Volume 57, Issue 2, February 2017, Pages: 137–150, Guohua An

    Version of Record online : 6 SEP 2016, DOI: 10.1002/jcph.804

  14. Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: In vitro and in vivo correlation

    The Journal of Clinical Pharmacology

    Volume 55, Issue 4, April 2015, Pages: 467–477, John P. Sabo, Jens Kort, Charles Ballow, Angela D.M. Kashuba, Manuel Haschke, Manuel Battegay, Birgit Girlich, Naitee Ting, Benjamin Lang, Wei Zhang, Curtis Cooper, Drané O'Brien, Eleanore Seibert, Tom S. Chan, Donald Tweedie and Yongmei Li

    Version of Record online : 14 JAN 2015, DOI: 10.1002/jcph.436

  15. Absence of an effect of T89 on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers

    The Journal of Clinical Pharmacology

    Volume 54, Issue 2, February 2014, Pages: 234–239, Ping Wang, He Sun, Liu Yang, Ling-Yan Li, Jing Hao, Dennis Ruff and Zhi-Xin Guo

    Version of Record online : 16 NOV 2013, DOI: 10.1002/jcph.209

  16. Pharmacokinetic Properties ofAnti-Influenza Neuraminidase Inhibitors

    The Journal of Clinical Pharmacology

    Volume 53, Issue 2, February 2013, Pages: 119–139, Kalayanee Chairat, Joel Tarning, Nicholas J. White and Niklas Lindegardh

    Version of Record online : 24 JAN 2013, DOI: 10.1177/0091270012440280

  17. You have free access to this content
    Pharmacokinetic-Guided Dosing of New Oral Cancer Agents

    The Journal of Clinical Pharmacology

    Volume 57, Issue S10, October 2017, Pages: S78–S98, Catherine J. Lucas and Jennifer H. Martin

    Version of Record online : 15 SEP 2017, DOI: 10.1002/jcph.937

  18. A Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts

    The Journal of Clinical Pharmacology

    Volume 56, Issue 10, October 2016, Pages: 1232–1242, Sarayu Arvind Pai and Nilima Kshirsagar

    Version of Record online : 1 APR 2016, DOI: 10.1002/jcph.720

  19. Selexipag in Pulmonary Arterial Hypertension: Most Updated Evidence From Recent Preclinical and Clinical Studies

    The Journal of Clinical Pharmacology

    Volume 57, Issue 5, May 2017, Pages: 547–557, Raktim K. Ghosh, Somedeb Ball, Avash Das, Dhrubajyoti Bandyopadhyay, Samhati Mondal, Debjit Saha and Anjan Gupta

    Version of Record online : 21 DEC 2016, DOI: 10.1002/jcph.834

  20. The Effect of Treatment of Vitamin D Deficiency on the Level of P-Selectin and hs-CRP in Patients With Thromboembolism: A Pilot Randomized Clinical Trial

    The Journal of Clinical Pharmacology

    Volume 57, Issue 1, January 2017, Pages: 40–47, Mohammad Esmaeil Hejazi, Faezeh Modarresi-Ghazani, Hadi Hamishehkar, Mehran Mesgari-Abbasi, Samaneh Dousti and Taher Entezari-Maleki

    Version of Record online : 28 JUN 2016, DOI: 10.1002/jcph.774